Stock A092730 NEOPHARM CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

News NeoPharm CO., LTD.

Equities

A092730

KR7092730001

End-of-day quote Korea S.E.
Other stock markets
 23:00:00 13/05/2024 BST 		5-day change 1st Jan Change
24,950 KRW -3.85% Intraday chart for NeoPharm CO., LTD. -1.77% -3.48%
2023 NeoPharm CO., LTD. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
2019 NeoPharm CO., LTD. announced that it has received KRW 31.970667276 billion in funding CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
NeoPharm CO., LTD. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
NeoPharm CO., LTD. announced that it has received KRW 31.970667276 billion in funding
CI
NeoPharm CO., LTD. announced that it expects to receive KRW 31.970667276 billion in funding
CI
Gpower, inc. cancelled the acquisition of 0.27% stake in NeoPharm Co., Ltd. from Byungduk Park.
CI
Gpower, inc. agreed to acquire 0.27% stake in NeoPharm Co., Ltd. from Byungduk Park for approximately KRW 780 million.
CI
HOPE BIOSCIENCES, INC. Acquires Worldwide Rights to Novel MERTK/AXL Inhibitor from Neopharm Co. Ltd
CI
Han Bul Cosmetics Co., Ltd. and an individual completed the acquisition of 29.39% stake in Neopharm Co Ltd from Ahn, Yong-Chan and 7 individuals.
CI
Han Bul Cosmetics Co., Ltd. and an individual signed a contract to acquire 29.39% stake in Neopharm Co Ltd from Yong-Chan Ahn and 7 individuals for KRW 72.8 billion.
CI
Neopharm Co Ltd(KOSDAQ:A092730) added to S&P Global BMI Index
CI
LEO Pharma A/S Enters Supply and Distribution Agreement with NeoPharm Co., Ltd. on Non-Prescription Skin Care Solutions
CI
Neopharm Co Ltd's Equity Buyback announced on February 10, 2014 has expired.
CI
Tranche Update on Neopharm Co Ltd's Equity Buyback Plan announced on February 10, 2014.
CI
Neopharm Co Ltd authorizes a Buyback Plan.
CI
Neopharm Co Ltd announces an Equity Buyback for KRW 1,000 million worth of its shares.
CI
Tranche Update on Neopharm Co Ltd's Equity Buyback Plan announced on July 9, 2013
CI
Neopharm Co Ltd s Equity Buyback announced on July 9, 2013 has expired with 166,483 shares for KRW 1,007.08 million.
CI
Neopharm Co Ltd announces an Equity Buyback
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A092730 Stock
  4. News NeoPharm CO., LTD.